Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 8/2012

01.12.2012 | Original Paper

MRI classification of asymmetric septal hypertrophic cardiomyopathy and its relation to the presence of risk factors

verfasst von: Yasuo Amano, Mitsunobu Kitamura, Morimasa Takayama, Masaki Tachi, Shinichiro Kumita

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Abstract

Asymmetric septal hypertrophic cardiomyopathy (ASH) is the common phenotype of hypertrophic cardiomyopathy (HCM). We sought to classify ASH using magnetic resonance imaging (MRI) and to determine whether the MRI classification of ASH is related to the presence of risk factors for HCM. Ninety-three patients with ASH underwent cine and delayed-enhancement MRI. The ASH was classified morphologically using cine MRI at end-diastole. We evaluated the association between the MRI findings and the presence of risk factors in the ASH. The ASH was classified into three subtypes by MRI: contiguous subtype showing various clinical and MRI features (57%), sigmoid subtype (29%) with fewer risk factors, and reverse-curve subtype (14%) in younger patients with the larger myocardial mass and delayed-enhancement, which were significantly related to the risk factors. MRI was used to classify ASH into three subtypes, which might be related to the presence of risk factors.
Literatur
1.
Zurück zum Zitat Maron BJ, Bonow RO, Cannon RO III, Leon MB, Estein SE (1987) Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med 316:780–789PubMedCrossRef Maron BJ, Bonow RO, Cannon RO III, Leon MB, Estein SE (1987) Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med 316:780–789PubMedCrossRef
2.
Zurück zum Zitat Wigle ED, Rakowski H, Kimball BP, Williams WG (1995) Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation 92:1680–1692PubMedCrossRef Wigle ED, Rakowski H, Kimball BP, Williams WG (1995) Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation 92:1680–1692PubMedCrossRef
3.
Zurück zum Zitat Marian AJ (2010) Hypertrophic cardiomyopathy: from genetics to treatment. Eur J Clin Invest 40:360–369PubMedCrossRef Marian AJ (2010) Hypertrophic cardiomyopathy: from genetics to treatment. Eur J Clin Invest 40:360–369PubMedCrossRef
4.
Zurück zum Zitat Maron BJ, Gottdiener JS, Epstein SE (1981) Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographical study of 125 patients. Am J Cardiol 48:418–428PubMedCrossRef Maron BJ, Gottdiener JS, Epstein SE (1981) Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographical study of 125 patients. Am J Cardiol 48:418–428PubMedCrossRef
5.
Zurück zum Zitat Klues HG, Schiffers A, Maron BJ (1995) Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 26:1699–1708PubMedCrossRef Klues HG, Schiffers A, Maron BJ (1995) Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 26:1699–1708PubMedCrossRef
6.
Zurück zum Zitat Turer AT, Samad Z, Valente AM, Parker MA, Hayes B, Kim RJ, Kisslo J, Wang A (2011) Anatomic and clinical correlates of septal morphology in hypertrophic cardiomyopathy. Eur J Echocardiogr 12:131–139PubMedCrossRef Turer AT, Samad Z, Valente AM, Parker MA, Hayes B, Kim RJ, Kisslo J, Wang A (2011) Anatomic and clinical correlates of septal morphology in hypertrophic cardiomyopathy. Eur J Echocardiogr 12:131–139PubMedCrossRef
7.
Zurück zum Zitat Binder J, Ommen SR, Gersh BJ, VanDriest SL, Tajik AJ, Nishimura RA, Ackerman MJ (2006) Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations. Mayo Clin Proc 81:459–467PubMedCrossRef Binder J, Ommen SR, Gersh BJ, VanDriest SL, Tajik AJ, Nishimura RA, Ackerman MJ (2006) Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations. Mayo Clin Proc 81:459–467PubMedCrossRef
8.
Zurück zum Zitat Rickers C, Wilke NM, Jerosch-Herold M, Casey SA, Panse P, Panse N, Weil J, Zenovich AG, Maron BJ (2005) Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 112:855–861PubMedCrossRef Rickers C, Wilke NM, Jerosch-Herold M, Casey SA, Panse P, Panse N, Weil J, Zenovich AG, Maron BJ (2005) Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 112:855–861PubMedCrossRef
9.
Zurück zum Zitat Moon JCC, Fisher NG, McKenna WJ, Pennell DJ (2004) Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 90:645–649PubMedCrossRef Moon JCC, Fisher NG, McKenna WJ, Pennell DJ (2004) Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 90:645–649PubMedCrossRef
10.
Zurück zum Zitat Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto J, Biller L, Lesser JR, Udelson JE, Manning WJ, Appelbaum E (2009) Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol 54:220–228PubMedCrossRef Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto J, Biller L, Lesser JR, Udelson JE, Manning WJ, Appelbaum E (2009) Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol 54:220–228PubMedCrossRef
11.
Zurück zum Zitat O’Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R, Webb J, Kulkarni M, Dawson D, Sulaibeekh L, Chandrasekaran B, Bucciarelli-Ducci C, Pasquale F, Cowie MR, McKenna WJ, Sheppard MN, Elliott PM, Pennell DJ, Prasad SK (2010) Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 56:867–874PubMedCrossRef O’Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R, Webb J, Kulkarni M, Dawson D, Sulaibeekh L, Chandrasekaran B, Bucciarelli-Ducci C, Pasquale F, Cowie MR, McKenna WJ, Sheppard MN, Elliott PM, Pennell DJ, Prasad SK (2010) Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 56:867–874PubMedCrossRef
12.
Zurück zum Zitat Bruder O, Wagner A, Jensen CJ, Schneider S, Ong P, Kispert EM, Nassenstein K, Schlosser T, Sabin GV, Sechtem U, Mahrholdt H (2010) Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 56:875–887PubMedCrossRef Bruder O, Wagner A, Jensen CJ, Schneider S, Ong P, Kispert EM, Nassenstein K, Schlosser T, Sabin GV, Sechtem U, Mahrholdt H (2010) Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 56:875–887PubMedCrossRef
13.
Zurück zum Zitat Kitaoka H, Doi Y, Casey SA, Hitomi N, Furuno T, Maron BJ (2003) Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States. Am J Cardiol 92:1183–1186PubMedCrossRef Kitaoka H, Doi Y, Casey SA, Hitomi N, Furuno T, Maron BJ (2003) Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States. Am J Cardiol 92:1183–1186PubMedCrossRef
14.
Zurück zum Zitat Chun EJ, Choi SI, Jin KN, Kwag HJ, Kim YJ, Choi BW, Lee W, Park JH (2010) Hypertrophic cardiomyopathy: assessment with MR imaging and multidetector CT. RadioGraphics 30:1309–1328PubMedCrossRef Chun EJ, Choi SI, Jin KN, Kwag HJ, Kim YJ, Choi BW, Lee W, Park JH (2010) Hypertrophic cardiomyopathy: assessment with MR imaging and multidetector CT. RadioGraphics 30:1309–1328PubMedCrossRef
15.
Zurück zum Zitat Brandenburg RO (1985) Cardiomyopathies and their role in sudden death. J Am Coll Cardiol 5:185B–189BPubMedCrossRef Brandenburg RO (1985) Cardiomyopathies and their role in sudden death. J Am Coll Cardiol 5:185B–189BPubMedCrossRef
16.
Zurück zum Zitat Maron BJ (2010) Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Circulation 121:445–456PubMedCrossRef Maron BJ (2010) Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Circulation 121:445–456PubMedCrossRef
17.
Zurück zum Zitat Olivotto I, Maron MS, Autore C, Lesser JR, Rega L, Casolo G, De Santis M, Quarta G, Nistri S, Cecchi F, Salton CJ, Udelson JE, Manning WJ, Maron BJ (2008) Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 52:559–566PubMedCrossRef Olivotto I, Maron MS, Autore C, Lesser JR, Rega L, Casolo G, De Santis M, Quarta G, Nistri S, Cecchi F, Salton CJ, Udelson JE, Manning WJ, Maron BJ (2008) Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 52:559–566PubMedCrossRef
18.
Zurück zum Zitat Levy D, Garrison RJ, Savage DD, Kannel WB (1990) Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 322:1561–1566PubMedCrossRef Levy D, Garrison RJ, Savage DD, Kannel WB (1990) Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 322:1561–1566PubMedCrossRef
19.
Zurück zum Zitat Adabag AS, Maron BJ, Appelbaum E, Harrigan CJ, Buros JL, Gibson M, Lesser JR, Hanna CA, Udelson JE, Manning WJ, Maron MS (2008) Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51:1369–1374PubMedCrossRef Adabag AS, Maron BJ, Appelbaum E, Harrigan CJ, Buros JL, Gibson M, Lesser JR, Hanna CA, Udelson JE, Manning WJ, Maron MS (2008) Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51:1369–1374PubMedCrossRef
20.
Zurück zum Zitat Harrigan CJ, Peters DC, Gibson CM, Maron BJ, Manning WJ, Maron MS, Applebaum E (2011) Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging. Radiology 258:128–133PubMedCrossRef Harrigan CJ, Peters DC, Gibson CM, Maron BJ, Manning WJ, Maron MS, Applebaum E (2011) Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging. Radiology 258:128–133PubMedCrossRef
Metadaten
Titel
MRI classification of asymmetric septal hypertrophic cardiomyopathy and its relation to the presence of risk factors
verfasst von
Yasuo Amano
Mitsunobu Kitamura
Morimasa Takayama
Masaki Tachi
Shinichiro Kumita
Publikationsdatum
01.12.2012
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 8/2012
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-012-0034-4

Weitere Artikel der Ausgabe 8/2012

The International Journal of Cardiovascular Imaging 8/2012 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.